The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Endocrine Disruptor Service Market Research Report 2025

Global Endocrine Disruptor Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1723965

No of Pages : 95

Ask Your Query
Synopsis
Highlights
The global Endocrine Disruptor Service market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Endocrine Disruptor Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Endocrine Disruptor Service is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Endocrine Disruptor Service in Enterprise is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Endocrine Disruptor Service include Eurofins Scientific, Charles River Laboratories, Creative Proteomics, LAUS Corp., Malvern Panalytical, Creative Bioarray, ZeClinics, Xenometrix and ToxStrategies, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Endocrine Disruption Screening, which accounted for % of the global market of Endocrine Disruptor Service in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Endocrine Disruptor Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Disruptor Service.
The Endocrine Disruptor Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Endocrine Disruptor Service market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine Disruptor Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Eurofins Scientific
Charles River Laboratories
Creative Proteomics
LAUS Corp.
Malvern Panalytical
Creative Bioarray
ZeClinics
Xenometrix
ToxStrategies
Smithers
Intertek
Fera Science
PerkinElmer
Compliance Services International
Stellixir Biotech
Product Type Insights
Global markets are presented by Endocrine Disruptor Service type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Endocrine Disruptor Service are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Endocrine Disruptor Service segment by Type
Endocrine Disruption Screening
Endocrine Disruptor Assessment
Other Customized Services
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Endocrine Disruptor Service market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Endocrine Disruptor Service market.
Endocrine Disruptor Service Segment by Application
Enterprise
Individual
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Endocrine Disruptor Service market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Disruptor Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Endocrine Disruptor Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Endocrine Disruptor Service industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Disruptor Service.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Disruptor Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruptor Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Endocrine Disruption Screening
1.2.3 Endocrine Disruptor Assessment
1.2.4 Other Customized Services
1.3 Market by Application
1.3.1 Global Endocrine Disruptor Service Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Enterprise
1.3.3 Individual
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruptor Service Market Perspective (2017-2028)
2.2 Endocrine Disruptor Service Growth Trends by Region
2.2.1 Endocrine Disruptor Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Endocrine Disruptor Service Historic Market Size by Region (2017-2022)
2.2.3 Endocrine Disruptor Service Forecasted Market Size by Region (2023-2028)
2.3 Endocrine Disruptor Service Market Dynamics
2.3.1 Endocrine Disruptor Service Industry Trends
2.3.2 Endocrine Disruptor Service Market Drivers
2.3.3 Endocrine Disruptor Service Market Challenges
2.3.4 Endocrine Disruptor Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruptor Service Players by Revenue
3.1.1 Global Top Endocrine Disruptor Service Players by Revenue (2017-2022)
3.1.2 Global Endocrine Disruptor Service Revenue Market Share by Players (2017-2022)
3.2 Global Endocrine Disruptor Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endocrine Disruptor Service Revenue
3.4 Global Endocrine Disruptor Service Market Concentration Ratio
3.4.1 Global Endocrine Disruptor Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruptor Service Revenue in 2021
3.5 Endocrine Disruptor Service Key Players Head office and Area Served
3.6 Key Players Endocrine Disruptor Service Product Solution and Service
3.7 Date of Enter into Endocrine Disruptor Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Disruptor Service Breakdown Data by Type
4.1 Global Endocrine Disruptor Service Historic Market Size by Type (2017-2022)
4.2 Global Endocrine Disruptor Service Forecasted Market Size by Type (2023-2028)
5 Endocrine Disruptor Service Breakdown Data by Application
5.1 Global Endocrine Disruptor Service Historic Market Size by Application (2017-2022)
5.2 Global Endocrine Disruptor Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Endocrine Disruptor Service Market Size (2017-2028)
6.2 North America Endocrine Disruptor Service Market Size by Country (2017-2022)
6.3 North America Endocrine Disruptor Service Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Endocrine Disruptor Service Market Size (2017-2028)
7.2 Europe Endocrine Disruptor Service Market Size by Country (2017-2022)
7.3 Europe Endocrine Disruptor Service Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruptor Service Market Size (2017-2028)
8.2 Asia-Pacific Endocrine Disruptor Service Market Size by Country (2017-2022)
8.3 Asia-Pacific Endocrine Disruptor Service Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Endocrine Disruptor Service Market Size (2017-2028)
9.2 Latin America Endocrine Disruptor Service Market Size by Country (2017-2022)
9.3 Latin America Endocrine Disruptor Service Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruptor Service Market Size (2017-2028)
10.2 Middle East & Africa Endocrine Disruptor Service Market Size by Country (2017-2022)
10.3 Middle East & Africa Endocrine Disruptor Service Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Detail
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Endocrine Disruptor Service Introduction
11.1.4 Eurofins Scientific Revenue in Endocrine Disruptor Service Business (2017-2022)
11.1.5 Eurofins Scientific Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Endocrine Disruptor Service Introduction
11.2.4 Charles River Laboratories Revenue in Endocrine Disruptor Service Business (2017-2022)
11.2.5 Charles River Laboratories Recent Development
11.3 Creative Proteomics
11.3.1 Creative Proteomics Company Detail
11.3.2 Creative Proteomics Business Overview
11.3.3 Creative Proteomics Endocrine Disruptor Service Introduction
11.3.4 Creative Proteomics Revenue in Endocrine Disruptor Service Business (2017-2022)
11.3.5 Creative Proteomics Recent Development
11.4 LAUS Corp.
11.4.1 LAUS Corp. Company Detail
11.4.2 LAUS Corp. Business Overview
11.4.3 LAUS Corp. Endocrine Disruptor Service Introduction
11.4.4 LAUS Corp. Revenue in Endocrine Disruptor Service Business (2017-2022)
11.4.5 LAUS Corp. Recent Development
11.5 Malvern Panalytical
11.5.1 Malvern Panalytical Company Detail
11.5.2 Malvern Panalytical Business Overview
11.5.3 Malvern Panalytical Endocrine Disruptor Service Introduction
11.5.4 Malvern Panalytical Revenue in Endocrine Disruptor Service Business (2017-2022)
11.5.5 Malvern Panalytical Recent Development
11.6 Creative Bioarray
11.6.1 Creative Bioarray Company Detail
11.6.2 Creative Bioarray Business Overview
11.6.3 Creative Bioarray Endocrine Disruptor Service Introduction
11.6.4 Creative Bioarray Revenue in Endocrine Disruptor Service Business (2017-2022)
11.6.5 Creative Bioarray Recent Development
11.7 ZeClinics
11.7.1 ZeClinics Company Detail
11.7.2 ZeClinics Business Overview
11.7.3 ZeClinics Endocrine Disruptor Service Introduction
11.7.4 ZeClinics Revenue in Endocrine Disruptor Service Business (2017-2022)
11.7.5 ZeClinics Recent Development
11.8 Xenometrix
11.8.1 Xenometrix Company Detail
11.8.2 Xenometrix Business Overview
11.8.3 Xenometrix Endocrine Disruptor Service Introduction
11.8.4 Xenometrix Revenue in Endocrine Disruptor Service Business (2017-2022)
11.8.5 Xenometrix Recent Development
11.9 ToxStrategies
11.9.1 ToxStrategies Company Detail
11.9.2 ToxStrategies Business Overview
11.9.3 ToxStrategies Endocrine Disruptor Service Introduction
11.9.4 ToxStrategies Revenue in Endocrine Disruptor Service Business (2017-2022)
11.9.5 ToxStrategies Recent Development
11.10 Smithers
11.10.1 Smithers Company Detail
11.10.2 Smithers Business Overview
11.10.3 Smithers Endocrine Disruptor Service Introduction
11.10.4 Smithers Revenue in Endocrine Disruptor Service Business (2017-2022)
11.10.5 Smithers Recent Development
11.11 Intertek
11.11.1 Intertek Company Detail
11.11.2 Intertek Business Overview
11.11.3 Intertek Endocrine Disruptor Service Introduction
11.11.4 Intertek Revenue in Endocrine Disruptor Service Business (2017-2022)
11.11.5 Intertek Recent Development
11.12 Fera Science
11.12.1 Fera Science Company Detail
11.12.2 Fera Science Business Overview
11.12.3 Fera Science Endocrine Disruptor Service Introduction
11.12.4 Fera Science Revenue in Endocrine Disruptor Service Business (2017-2022)
11.12.5 Fera Science Recent Development
11.13 PerkinElmer
11.13.1 PerkinElmer Company Detail
11.13.2 PerkinElmer Business Overview
11.13.3 PerkinElmer Endocrine Disruptor Service Introduction
11.13.4 PerkinElmer Revenue in Endocrine Disruptor Service Business (2017-2022)
11.13.5 PerkinElmer Recent Development
11.14 Compliance Services International
11.14.1 Compliance Services International Company Detail
11.14.2 Compliance Services International Business Overview
11.14.3 Compliance Services International Endocrine Disruptor Service Introduction
11.14.4 Compliance Services International Revenue in Endocrine Disruptor Service Business (2017-2022)
11.14.5 Compliance Services International Recent Development
11.15 Stellixir Biotech
11.15.1 Stellixir Biotech Company Detail
11.15.2 Stellixir Biotech Business Overview
11.15.3 Stellixir Biotech Endocrine Disruptor Service Introduction
11.15.4 Stellixir Biotech Revenue in Endocrine Disruptor Service Business (2017-2022)
11.15.5 Stellixir Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Endocrine Disruptor Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Endocrine Disruption Screening
Table 3. Key Players of Endocrine Disruptor Assessment
Table 4. Key Players of Other Customized Services
Table 5. Global Endocrine Disruptor Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Endocrine Disruptor Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Endocrine Disruptor Service Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Endocrine Disruptor Service Market Share by Region (2017-2022)
Table 9. Global Endocrine Disruptor Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Endocrine Disruptor Service Market Share by Region (2023-2028)
Table 11. Endocrine Disruptor Service Market Trends
Table 12. Endocrine Disruptor Service Market Drivers
Table 13. Endocrine Disruptor Service Market Challenges
Table 14. Endocrine Disruptor Service Market Restraints
Table 15. Global Endocrine Disruptor Service Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Endocrine Disruptor Service Market Share by Players (2017-2022)
Table 17. Global Top Endocrine Disruptor Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruptor Service as of 2021)
Table 18. Ranking of Global Top Endocrine Disruptor Service Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Endocrine Disruptor Service Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Endocrine Disruptor Service Product Solution and Service
Table 22. Date of Enter into Endocrine Disruptor Service Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endocrine Disruptor Service Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Endocrine Disruptor Service Revenue Market Share by Type (2017-2022)
Table 26. Global Endocrine Disruptor Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Endocrine Disruptor Service Revenue Market Share by Type (2023-2028)
Table 28. Global Endocrine Disruptor Service Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Endocrine Disruptor Service Revenue Market Share by Application (2017-2022)
Table 30. Global Endocrine Disruptor Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Endocrine Disruptor Service Revenue Market Share by Application (2023-2028)
Table 32. North America Endocrine Disruptor Service Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Endocrine Disruptor Service Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Endocrine Disruptor Service Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Endocrine Disruptor Service Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Endocrine Disruptor Service Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Endocrine Disruptor Service Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Endocrine Disruptor Service Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Endocrine Disruptor Service Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Endocrine Disruptor Service Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Endocrine Disruptor Service Market Size by Country (2023-2028) & (US$ Million)
Table 42. Eurofins Scientific Company Detail
Table 43. Eurofins Scientific Business Overview
Table 44. Eurofins Scientific Endocrine Disruptor Service Product
Table 45. Eurofins Scientific Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 46. Eurofins Scientific Recent Development
Table 47. Charles River Laboratories Company Detail
Table 48. Charles River Laboratories Business Overview
Table 49. Charles River Laboratories Endocrine Disruptor Service Product
Table 50. Charles River Laboratories Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 51. Charles River Laboratories Recent Development
Table 52. Creative Proteomics Company Detail
Table 53. Creative Proteomics Business Overview
Table 54. Creative Proteomics Endocrine Disruptor Service Product
Table 55. Creative Proteomics Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 56. Creative Proteomics Recent Development
Table 57. LAUS Corp. Company Detail
Table 58. LAUS Corp. Business Overview
Table 59. LAUS Corp. Endocrine Disruptor Service Product
Table 60. LAUS Corp. Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 61. LAUS Corp. Recent Development
Table 62. Malvern Panalytical Company Detail
Table 63. Malvern Panalytical Business Overview
Table 64. Malvern Panalytical Endocrine Disruptor Service Product
Table 65. Malvern Panalytical Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 66. Malvern Panalytical Recent Development
Table 67. Creative Bioarray Company Detail
Table 68. Creative Bioarray Business Overview
Table 69. Creative Bioarray Endocrine Disruptor Service Product
Table 70. Creative Bioarray Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 71. Creative Bioarray Recent Development
Table 72. ZeClinics Company Detail
Table 73. ZeClinics Business Overview
Table 74. ZeClinics Endocrine Disruptor Service Product
Table 75. ZeClinics Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 76. ZeClinics Recent Development
Table 77. Xenometrix Company Detail
Table 78. Xenometrix Business Overview
Table 79. Xenometrix Endocrine Disruptor Service Product
Table 80. Xenometrix Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 81. Xenometrix Recent Development
Table 82. ToxStrategies Company Detail
Table 83. ToxStrategies Business Overview
Table 84. ToxStrategies Endocrine Disruptor Service Product
Table 85. ToxStrategies Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 86. ToxStrategies Recent Development
Table 87. Smithers Company Detail
Table 88. Smithers Business Overview
Table 89. Smithers Endocrine Disruptor Service Product
Table 90. Smithers Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 91. Smithers Recent Development
Table 92. Intertek Company Detail
Table 93. Intertek Business Overview
Table 94. Intertek Endocrine Disruptor ServiceProduct
Table 95. Intertek Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 96. Intertek Recent Development
Table 97. Fera Science Company Detail
Table 98. Fera Science Business Overview
Table 99. Fera Science Endocrine Disruptor ServiceProduct
Table 100. Fera Science Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 101. Fera Science Recent Development
Table 102. PerkinElmer Company Detail
Table 103. PerkinElmer Business Overview
Table 104. PerkinElmer Endocrine Disruptor ServiceProduct
Table 105. PerkinElmer Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 106. PerkinElmer Recent Development
Table 107. Compliance Services International Company Detail
Table 108. Compliance Services International Business Overview
Table 109. Compliance Services International Endocrine Disruptor ServiceProduct
Table 110. Compliance Services International Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 111. Compliance Services International Recent Development
Table 112. Stellixir Biotech Company Detail
Table 113. Stellixir Biotech Business Overview
Table 114. Stellixir Biotech Endocrine Disruptor ServiceProduct
Table 115. Stellixir Biotech Revenue in Endocrine Disruptor Service Business (2017-2022) & (US$ Million)
Table 116. Stellixir Biotech Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocrine Disruptor Service Market Share by Type: 2021 VS 2028
Figure 2. Endocrine Disruption Screening Features
Figure 3. Endocrine Disruptor Assessment Features
Figure 4. Other Customized Services Features
Figure 5. Global Endocrine Disruptor Service Market Share by Application in 2021 & 2028
Figure 6. Enterprise Case Studies
Figure 7. Individual Case Studies
Figure 8. Endocrine Disruptor Service Report Years Considered
Figure 9. Global Endocrine Disruptor Service Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Endocrine Disruptor Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Endocrine Disruptor Service Market Share by Region: 2021 VS 2028
Figure 12. Global Endocrine Disruptor Service Market Share by Players in 2021
Figure 13. Global Top Endocrine Disruptor Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruptor Service as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Endocrine Disruptor Service Revenue in 2021
Figure 15. North America Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Endocrine Disruptor Service Market Share by Country (2017-2028)
Figure 17. United States Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Endocrine Disruptor Service Market Share by Country (2017-2028)
Figure 21. Germany Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Endocrine Disruptor Service Market Share by Region (2017-2028)
Figure 29. China Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Endocrine Disruptor Service Market Share by Country (2017-2028)
Figure 37. Mexico Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Endocrine Disruptor Service Market Share by Country (2017-2028)
Figure 41. Turkey Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Endocrine Disruptor Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Eurofins Scientific Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 44. Charles River Laboratories Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 45. Creative Proteomics Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 46. LAUS Corp. Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 47. Malvern Panalytical Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 48. Creative Bioarray Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 49. ZeClinics Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 50. Xenometrix Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 51. ToxStrategies Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 52. Smithers Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 53. Intertek Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 54. Fera Science Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 55. PerkinElmer Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 56. Compliance Services International Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 57. Stellixir Biotech Revenue Growth Rate in Endocrine Disruptor Service Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock